InspireMD (NSPR) Long-Term Deferred Tax (2015 - 2016)

InspireMD (NSPR) reported Long-Term Deferred Tax of $29.6 million for Q4 2016, up 2.75% on a YoY basis from $28.8 million in Q1 2016, and up 2.75% quarter-over-quarter from $28.8 million in Q4 2015.

InspireMD (NSPR) Long-Term Deferred Tax (2015 - 2016) Analysis & Trends

InspireMD has reported Long-Term Deferred Tax for 2 years, with the latest figure at $29.6 million in Q4 2016.

  • For the quarter ending Q4 2016, Long-Term Deferred Tax rose 2.75% year-over-year to $29.6 million; the trailing twelve-month figure through Dec 2016 stood at $29.6 million (up 2.75% YoY), and the FY2016 full-year result was $29.6 million, up 2.75% from the prior year.
  • Long-Term Deferred Tax for Q4 2016 stood at $29.6 million, up from $28.8 million in the prior quarter.
  • The five-year high for Long-Term Deferred Tax was $29.6 million in Q4 2016, with the low at $28.8 million in Q4 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 InspireMD 45.74 Mn -8.48 Mn 1.18 Mn

Historic Data

Download Data
DateValue
Dec 31, 2016 29.58 Mn
Dec 31, 2015 28.79 Mn